| 74848-3 |
Lymphocytes/Cells |
NFr |
Lymph node |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphocytes/cells in Lymph node by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
74848-3 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphocytes NFr LN Manual |
|
|
|
|
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 74849-1 |
Plasma cells/Cells |
NFr |
Lymph node |
Pt |
Qn |
Manual count |
|
ACTIVE |
Plasma cells/cells in Lymph node by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
74849-1 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Plasma Cells NFr LN Manual |
|
|
|
|
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Manl; Myeloma cells; Number fraction; Percent; Plasmacyte; Plasmacytes; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 7485-6 |
Iva xanthifolia Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Burweed marshelder IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
7485-6 |
|
|
|
|
Both |
|
|
|
0 |
Burweed marshelder IgG Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Burweed Marsh elder; Burweed marshelder; Immune globulin G; Immunoglobulin G; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
1.0h(2) |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 74850-9 |
Lymphoblasts/Cells |
NFr |
Lymph node |
Pt |
Qn |
Manual count |
|
ACTIVE |
Lymphoblasts/cells in Lymph node by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
74850-9 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Lymphoblasts NFr LN Manual |
|
|
|
|
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Lymphoblast; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 74851-7 |
Blasts/Cells |
NFr |
Lymph node |
Pt |
Qn |
Manual count |
|
ACTIVE |
Blasts/cells in Lymph node by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
74851-7 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Blasts NFr LN Manual |
|
|
|
|
|
Blast; Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 74852-5 |
Mesothelial cells/Cells |
NFr |
Lymph node |
Pt |
Qn |
Manual count |
|
ACTIVE |
Mesothelial cells/cells in Lymph node by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
74852-5 |
|
Manual count |
|
|
Both |
|
|
|
0 |
Mesothl Cell NFr LN Manual |
|
|
|
|
|
Cell; Cellularity; HEMATOLOGY/CELL COUNTS; LN; Manl; Mesothl; Mesothl Cell; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.79 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 74853-3 |
HIV 1 proviral DNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
HIV 1 proviral DNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74853-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HIV 1 pro DNA Spec Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.69 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from Pr to Threshold to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74854-1 |
HIV 1 proviral DNA |
NCnc |
Bld |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
HIV 1 proviral DNA [#/volume] (viral load) in Blood by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
copies/mL |
|
|
|
|
|
|
MICRO |
|
74854-1 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HIV 1 pro DNA # Bld NAA+probe |
|
|
|
|
|
#; 3 Self-Sustaining Sequence Replication; 3SR SR; ABS; absolute; absolutes; AIDS; Amplif; Amplification; Amplified; Blood; Cnt; Count; Count/volume; CT; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Number concentration; Number Concentration (count/vol); PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood |
2.63 |
2.48 |
|
|
|
|
|
|
|
{copies}/mL |
|
|
|
0 |
| 74855-8 |
HIV 1 proviral DNA |
LnCnc |
XXX |
Pt |
Qn |
Probe.amp.tar |
|
ACTIVE |
HIV 1 proviral DNA [Log #/volume] (viral load) in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
Log cells/mL |
|
|
|
|
|
|
MICRO |
|
74855-8 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HIV 1 pro DNA Spec NAA+probe-Log# |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log NCNC; Log#; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Viral load |
2.69 |
2.48 |
|
|
|
|
|
|
|
{Log_cells}/mL |
|
|
|
0 |
| 74856-6 |
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
HIV 1 group O RNA+HIV 1 group M RNA+HIV 2 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74856-6 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HIV1+2+HCV+HBV DNA SerPl Donr Ql NAA+pr |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; AIDS; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Donr; HBV; HCV; Hep; Hep B; Hep C; Hepatis; Hepatit; HepB; HIV type 1; HIV type 2; HIV type I; HIV type II; HIV1; HIV1+HIV2+HCV+HBV; Human immunodeficiency virus; i; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74857-4 |
West Nile Virus RNA |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
West Nile virus RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74857-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
WNV RNA SerPl Donr Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Donr; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WNV |
2.63 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74858-2 |
Hepatitis E virus genotypes 1+2+3+4 RNA |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Hepatitis E virus genotypes 1+2+3+4 RNA [Presence] in Serum or Plasma from Donor by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
74858-2 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
HEV 1+2+3+4 RNA SerPl Donr Ql NAA+probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Donr; Hep; Hep E; Hepatis; Hepatit; Hepatology; HEV; HEV 1+2+3+4; HEV 1-4 RNA; i; ID; II; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Liver; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.63 |
2.48 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 74859-0 |
Ethanol |
MCnc |
Bld |
Pt |
Qn |
Estimated from serum or plasma level |
|
ACTIVE |
Ethanol [Mass/volume] in Blood Estimated from serum or plasma level |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
Blood alcohol level = (Serum or plasma ethanol/conversion factor)/1000, where conversion factors range from 1.10-1.20) |
|
|
|
DRUG/TOX |
|
74859-0 |
|
Estimated from serum or plasma level |
|
|
Observation |
|
|
|
0 |
Bld Ethanol Est from SerPl-mCnc |
|
|
|
|
|
Alc; Alcohol; Blood; DRUG/TOXICOLOGY; Drugs; Est; Est from SerPl; estimation; Ethyl alcohol; EtOH; Level; Levels; Levl; LV; LVL; Mass concentration; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random; Ser; SR; WB; Whole blood |
2.73 |
2.48 |
|
|
|
|
|
|
|
% |
|
|
Release 2.67: FORMULA: Added "serum" to formula since blood alcohol level can be calculated from serum or plasma levels.; METHOD_TYP: Added "or plasma" to Method since blood alcohol levels can be estimated from serum or plasma. |
0 |
| 7486-4 |
Mattress dust Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Mattress dust IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7486-4 |
|
|
|
|
Both |
|
|
|
0 |
Mattress Dust IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
| 74860-8 |
ERBB2 gene copy number/nucleus |
EntNum |
Tiss |
Pt |
Qn |
FISH |
|
ACTIVE |
ERBB2 gene copy number/nucleus in Tissue by FISH |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
MOLPATH |
|
74860-8 |
|
FISH |
|
|
Observation |
|
|
|
0 |
ERBB2 copy num/nucleus EntNum Tiss FISH |
|
|
|
|
|
breast cancer; CD340; c-erb B2; Entitic; Entitic number; ErbB-2; ERBB2 copy num; erb-b2 receptor tyrosine kinase 2; Fluorescent in situ hybridization; Genetics; HER2; HER-2; HER2/neu; HER-2/neu; Heredity; Heritable; Inherited; MLN 19; Molecular pathology; MOLPATH; NEU; NGL; No; Num; p185; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; TKR1; v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog) |
2.73 |
2.48 |
|
|
|
|
|
|
|
{#} |
|
|
Release 2.70: COMPONENT: Corrected the gene name based on the LOINC model to use the approved HGNC name for the gene that encodes the HER2 receptor.; Previous Releases: Updated "signals" in Component to "copy number" to align with current nomenclature and similar terms |
0 |
| 74861-6 |
Chromosome 17 copy number/nucleus |
EntNum |
Tiss |
Pt |
Qn |
FISH |
|
ACTIVE |
Chromosome 17 copy number/nucleus in Tissue by FISH |
|
MIN |
DefinitionDescription |
|
|
# |
|
|
|
|
|
|
MOLPATH |
|
74861-6 |
|
FISH |
|
|
Observation |
|
|
|
0 |
Chr 17 copy num/nucleus EntNum Tiss FISH |
|
|
|
|
|
CEP17; Chr 17 copy num; Chromosom; Chromosome 17 centromere; Chromosome Enumeration Probe 17; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified |
2.73 |
2.48 |
|
|
|
|
|
|
|
{#} |
|
|
Updated Component from "CEP17 signals" to "Chromosome 17 copy number" to align with current nomenclature and similar terms |
0 |
| 74862-4 |
IgG.kappa |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgG.kappa [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74862-4 |
|
|
|
|
Both |
|
|
|
0 |
IgG Kappa SerPl-mCnc |
|
|
|
|
|
Chemistry; heavy chain; IgG Kappa; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74863-2 |
IgG.lambda |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgG.lambda [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74863-2 |
|
|
|
|
Both |
|
|
|
0 |
IgG lamba SerPl-mCnc |
|
|
|
|
|
Chemistry; heavy chain; IgG lamba; Immune globulin G; Immunoglobulin G; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74864-0 |
IgA.kappa |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgA.kappa [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74864-0 |
|
|
|
|
Both |
|
|
|
0 |
IgA kappa SerPl-mCnc |
|
|
|
|
|
Chemistry; heavy chain; IgA kappa; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74865-7 |
IgA.lambda |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgA.lambda [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74865-7 |
|
|
|
|
Both |
|
|
|
0 |
IgA lamba SerPl-mCnc |
|
|
|
|
|
Chemistry; heavy chain; IgA lamba; Immune globulin A; Immunoglobulin A; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74866-5 |
IgM.kappa |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgM.kappa [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74866-5 |
|
|
|
|
Both |
|
|
|
0 |
IgM kappa SerPl-mCnc |
|
|
|
|
|
Chemistry; IgM kappa; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74867-3 |
IgM.lambda |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgM.lambda [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
CHEM |
|
74867-3 |
|
|
|
|
Both |
|
|
|
0 |
IgM lambda SerPl-mCnc |
|
|
|
|
|
Chemistry; IgM lambda; Immune globulin M; Immunoglobulin M; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
g/L |
|
|
|
0 |
| 74868-1 |
IgG.kappa/IgG.lambda |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgG.kappa/IgG.lambda [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
IgG kappa (unit g/L) is divided by IgG lambda (unit: g/L) to calculate the IgG kappa/lambda-ratio. |
|
|
|
CHEM |
|
74868-1 |
|
|
|
|
Both |
|
|
|
0 |
IgG Kappa/G lambda SerPl |
|
|
|
|
|
Chemistry; G lambda; heavy chain; IgG Kappa; IgG lamba; Immune globulin G; Immunoglobulin G; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 74869-9 |
IgA.kappa/IgA.lambda |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
IgA.kappa/IgA.lambda [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
IgA kappa (unit g/L) is divided by IgA lambda (unit: g/L) to calculate the IgA kappa/lambda-ratio. |
|
|
|
CHEM |
|
74869-9 |
|
|
|
|
Both |
|
|
|
0 |
IgA kappa/A lambda SerPl |
|
|
|
|
|
A lambda; Chemistry; heavy chain; IgA kappa; IgA lamba; Immune globulin A; Immunoglobulin A; Mass concentration ratio; Mass ratio; MCRto; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.48 |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 7487-2 |
Mayfly Ab.IgE |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Mayfly IgE Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
kIU/L |
|
|
|
|
|
|
ALLERGY |
|
7487-2 |
|
|
|
|
Both |
|
|
|
0 |
Mayfly IgE Qn |
|
|
|
Y |
|
ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.42 |
1.0h(2) |
|
|
|
|
|
|
|
k[IU]/L |
|
|
|
0 |
